APA (7th ed.) Citation

YA, L., Q, J., Y, Z., Q, D., S, Y., Z, W., . . . J, L. (2020). Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133. Journal of medicinal chemistry, 63(6), 2958. https://doi.org/10.1021/acs.jmedchem.9b01624

Chicago Style (17th ed.) Citation

YA, Liu, et al. "Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133." Journal of Medicinal Chemistry 63, no. 6 (2020): 2958. https://doi.org/10.1021/acs.jmedchem.9b01624.

MLA (9th ed.) Citation

YA, Liu, et al. "Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133." Journal of Medicinal Chemistry, vol. 63, no. 6, 2020, p. 2958, https://doi.org/10.1021/acs.jmedchem.9b01624.